| Analyst | Bewertung | Kursziel | Kurs | Abstand | Datum |
|---|---|---|---|---|---|
| JPMorgan | 185,14 € | 152,3307 € | 32,8053 € | 02.06.26 | |
| Barclays | 190,69 € | 154,3105 € | 36,38 € | 01.06.26 | |
| Jefferies | 207,79 € | 160,239 € | 47,553 € | 13.05.26 | |
| UBS | 202,08 € | 174,2208 € | 27,8624 € | 10.04.26 | |
| Deutsche Bank | 133,10 € | 158,9392 € | -25,8382 € | 26.03.26 | |
| Berenberg | 196,93 € | 167,2852 € | 29,6428 € | 16.03.26 | |
| Bernstein | 235,28 € | 173,2844 € | 61,9941 € | 13.02.26 | |
| DZ | 173,65 € | 172,2419 € | 1,4081 € | 12.02.26 | |
| Goldman | 188,57 € | - € | - € | 28.01.26 |
| Name | Positiv | Neutral | Negativ | Ø Kursziel | Kurs | Abstand |
|---|---|---|---|---|---|---|
| AstraZeneca plc | 7 | 1 | 1 | 190,36 € | 157,40 € | 32,96 € |
| Glaxo Smith Kline plc | 2 | 4 | 2 | 23,87 € | 22,10 € | 1,77 € |